Cyrusone Inc (CONE)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
| 12-2016 | 12-2015 | 12-2014 | 12-2013 | 12-2012 | |
| Sales | 529,100 | 399,300 | 330,900 | 263,500 | 220,800 |
| Total expenses | 458,600 | 376,500 | 290,900 | 251,900 | 204,500 |
| Operating Income | 70,500 | 22,800 | 40,000 | 11,600 | 16,300 |
| Interest Expense | 48,800 | 41,200 | 39,500 | 43,700 | 41,800 |
| Other Income | 0 | 0 | -13,600 | -1,200 | 0 |
| Pre-tax Income | 21,700 | -18,400 | -13,100 | -33,300 | -25,500 |
| Income Tax | 1,800 | 1,800 | 1,400 | 2,300 | -5,100 |
| Net Income Continuous | 19,900 | -20,200 | -14,500 | -35,600 | -20,400 |
| Net Income Discontinuous | N/A | N/A | N/A | -200 | 100 |
| Minority Interests | N/A | -4,800 | -6,700 | -10,300 | N/A |
| Net Income | $19,900 | $-15,400 | $-7,800 | $-25,500 | $-20,300 |
| EPS Basic Continuous Ops | 0.25 | -0.37 | -0.50 | -1.70 | N/A |
| EPS Basic Discontinuous Ops | N/A | N/A | N/A | -0.01 | N/A |
| EPS Basic Total Ops | 0.24 | -0.30 | -0.30 | -1.22 | N/A |
| EPS Diluted Continuous Ops | 0.25 | -0.37 | -0.50 | -1.70 | N/A |
| EPS Diluted Discontinuous Ops | N/A | N/A | N/A | -0.01 | N/A |
| EPS Diluted Total Ops | 0.24 | -0.30 | -0.30 | -1.22 | N/A |
| EPS Diluted Before Non-Recurring Items | 0.25 | N/A | N/A | N/A | N/A |
| EBITDA(a) | $259,300 | $164,300 | $158,000 | $106,800 | $89,700 |